We’re excited to have received project funding fro

We’re excited to have received project funding from the @CrohnsColitisFn to support our ongoing programme of LBT f… https://t.co/EEhywv8ewe

高木さんを屋上に呼んでるぞw

Crispy Innovation To Drive The Biosimilars Market – https://t.co/HmApU8OCcM

How are #biosimilar medicines approved? The main part of the evaluation is a detailed head-to-head comparison of th… https://t.co/4JlzoNxmmk

When I was in the Face of Northern Ireland back in 2019 and Raising money for Cancer. I was very sick at the time w… https://t.co/Sj5xNREOCu

ESPGHAN has launched a new online tool for #CrohnsDisease, which outlines the treatment pathways for the condition.… https://t.co/npnpsB0LYJ

Podcast Daily Tech Conversation

Duncan Emerton at Pharma Intelligence on the biosimilars opportunity propelling Bi… https://t.co/CvInNeKy8K

Duncan Emerton at Pharma Intelligence on the biosimilars opportunity propelling Biocon’s $3.3 bln Viatris deal https://t.co/rubwz4pHZN

Duncan Emerton at Pharma Intelligence on the biosimilars opportunity propelling Biocon’s $3.3 bln Viatris deal https://t.co/rubwz47yLF

Per Gesetz soll ab August 2022 die Regelung gelten, dass #Biosimilars automatisch untereinander ausgetauscht werden… https://t.co/NsSoWQVf2x